8-K: Select Medical Holdings Reports Q1 2025 Results, Announces Cash Dividend

Select Medical Holdings Corporation announced its first quarter 2025 financial results, including a revenue increase of 2.4% and the declaration of a cash dividend of $0.0625 per share.

Summary

• Select Medical Holdings Corporation announced its financial results for the first quarter ended March 31, 2025.
• Revenue increased by 2.4% to $1,353.2 million, compared to $1,321.2 million for the same quarter last year.
• Income from continuing operations before other income and expense was $112.7 million, down from $118.5 million in the prior year.
• Net income from continuing operations increased 21.5% to $74.7 million.
• Adjusted EBITDA was $151.4 million, compared to $165.8 million in the same quarter last year.
• Earnings per common share from continuing operations increased 33.3% to $0.44.
• The company completed a tax-free distribution of Concentra shares on November 25, 2024, and Concentra's results are now presented as discontinued operations.
• The Board declared a cash dividend of $0.0625 per share, payable on or about May 29, 2025, to stockholders of record as of May 15, 2025.
• Select Medical is adjusting its 2025 business outlook for revenue and Adjusted EBITDA and reaffirming its 2025 business outlook for fully diluted earnings per share.
• For fiscal year 2025, Select Medical expects revenue to be in the range of $5.3 billion to $5.5 billion, Adjusted EBITDA to be in the range of $510.0 million to $530.0 million, and fully diluted earnings per share to be in the range of $1.09 to $1.19.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue and EPS increased, Adjusted EBITDA decreased, and the company faces several risks. The dividend announcement is a positive sign.

Positives

• Overall revenue increased by 2.4% in Q1 2025.
• Income from continuing operations, net of tax, saw a significant increase of 21.5%.
• Earnings per share from continuing operations increased by 33.3%.
• The company declared a cash dividend of $0.0625 per share.
• The rehabilitation hospital segment saw a revenue increase of 15.7% and an Adjusted EBITDA increase of 14.7%.

Negatives

• Income from continuing operations before other income and expense decreased by 4.8%.
• Adjusted EBITDA decreased from $165.8 million to $151.4 million.
• The critical illness recovery hospital segment experienced a revenue decrease of 2.9% and a significant Adjusted EBITDA decrease of 25.3%.

Risks

• Changes in government reimbursement policies could reduce revenue and profitability.
• Adverse economic conditions, including inflation, could increase labor and other costs.
• Shortages of qualified healthcare professionals could limit the ability to staff facilities.
• Public health threats, such as pandemics, could negatively impact the business.
• Failure to maintain Medicare certifications could cause revenue and profitability to decline.
• Security breaches of information technology systems could lead to legal and reputational harm.
• Competition may limit the company's ability to grow and result in a decrease in revenue and profitability.

Future Outlook

Select Medical is adjusting its 2025 business outlook for revenue and Adjusted EBITDA and reaffirming its 2025 business outlook for fully diluted earnings per share, expecting revenue between $5.3 billion and $5.5 billion, Adjusted EBITDA between $510.0 million and $530.0 million, and fully diluted earnings per share between $1.09 and $1.19.

Industry Context

The healthcare industry is facing challenges related to reimbursement, labor costs, and staffing shortages, which are reflected in Select Medical's discussion of risks and outlook.

Comparison to Industry Standards

• Select Medical operates in the critical illness recovery, rehabilitation, and outpatient rehabilitation sectors.
• Competitors include Encompass Health (EHC) in the rehabilitation hospital segment and U.S. Physical Therapy (USPH) in the outpatient rehabilitation segment.
• The Adjusted EBITDA margins for Select Medical's segments can be compared to those of its competitors to assess relative performance.
• For example, Encompass Health typically reports Adjusted EBITDA margins in the range of 20-25% for its rehabilitation hospitals, which is comparable to Select Medical's 22.9% margin in that segment.
• U.S. Physical Therapy's Adjusted EBITDA margins are typically in the range of 10-12%, higher than Select Medical's 7.9% margin in the outpatient rehabilitation segment.

Stakeholder Impact

• Shareholders will receive a cash dividend of $0.0625 per share.
• Employees may be affected by cost-cutting measures or staffing adjustments.
• Customers will likely see continued services at existing facilities.
• Suppliers may experience changes in demand based on the company's financial performance.
• Creditors should be aware of the company's debt levels and ability to generate cash flow.

Next Steps

• Select Medical will host a conference call on May 2, 2025, to discuss the results and outlook.
• The company will continue to execute its stock repurchase program until December 31, 2025.
• Management will focus on navigating challenges related to reimbursement, labor costs, and staffing shortages.

Key Dates

Keywords

financial results, cash dividend, Select Medical, Adjusted EBITDA, revenue, earnings, healthcare